iPSCs and fibroblast subclones from the same fibroblast population contain comparable levels of sequence variations
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Significance: One important unsolved question in the stem cell field is, do induced pluripotent stem cells (iPSCs) have more mutations than other cultured somatic cells because of the reprogramming process? In this work, we took a novel approach to interrogate the genome integrity of iPSCs by comparing mutational load of clonal fibroblast lines and iPSC lines derived from the same fibroblast parental cells. Whole exome sequencing demonstrates that iPSCs and clonal fibroblasts have comparable numbers of new mutations, as compared with their parental fibroblasts. Deep, targeted resequencing also shows that greater than 90% of these mutations are random, preexisting sequence variants in small subsets of the parental fibroblast population. Our data strongly suggest that reprogramming process is not mutagenic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, K., Li, M., Hadley, D., Liu, R., Glessner, J., Grant, S. F. A., Hakonarson, H., & Bucan, M. (2007) · Genome Research · doi:10.1101/gr.6861907 · Cited by 1,792
Somatic coding mutations in human induced pluripotent stem cells
Gore, A., Li, Z., Fung, H.-L., Young, J. E., Agarwal, S., Antosiewicz-Bourget, J., Canto, I., Giorgetti, A., Israel, M. A., Kiskinis, E., et al. (2011) · Nature · doi:10.1038/nature09805 · Cited by 1,273
Laurent, L. C., Ulitsky, I., Slavin, I., Tran, H., Schork, A., Morey, R., Lynch, C., Harness, J. V., Lee, S., Barrero, M. J., et al. (2011) · Cell stem cell · doi:10.1016/j.stem.2010.12.003 · Cited by 890 · cited 4×
“Interestingly, we identified a mosaic translocation event, t(5;11)(q35;q13), that has been previously reported to be associated with acute myeloid leukemia (AML) subtype M2, in one fibroblast subclone where the parental fibroblast sample (PF1) was isolated from a patient with FPD harboring the Y260X mutation in RUNX1…”
BackgroundMethodInfluentialGaritaonandia, I., Amir, H., Boscolo, F. S., Wambua, G. K., Schultheisz, H. L., Sabatini, K., Morey, R., Waltz, S., Wang, Y.-C., Tran, H., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0118307 · Cited by 150
Whole-genome mutational burden analysis of three pluripotency induction methods
Bhutani, K., Nazor, K. L., Williams, R., Tran, H., Dai, H., Džakula, Ž., Cho, E. H., Pang, A. W. C., Rao, M., Cao, H., et al. (2016) · Nature Communications · doi:10.1038/ncomms10536 · Cited by 129 · cited 1×
“However, several studies also suggested that many of the “de novo” variants were either inherited rare preexisting variations in the founder source cells or benign variants regardless of reprogramming method used (1, 9, 15, 16).”
BackgroundReprogramming to pluripotency can conceal somatic cell chromosomal instability
Hamada, M., Malureanu, L. A., Wijshake, T., Zhou, W., & van Deursen, J. M. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002913 · Cited by 16 · cited 4×
“Interestingly, we identified a mosaic translocation event, t(5;11)(q35;q13), that has been previously reported to be associated with acute myeloid leukemia (AML) subtype M2, in one fibroblast subclone where the parental fibroblast sample (PF1) was isolated from a patient with FPD harboring the Y260X mutation in RUNX1…”
BackgroundMethodInfluential
Cited by
Pluripotent Stem Cell-Based Cell Therapy—Promise and Challenges
Yamanaka, S. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2020.09.014 · Cited by 1,213
Modeling Alzheimer’s disease with iPSC-derived brain cells
Penney, J., Ralvenius, W. T., & Tsai, L.-H. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0468-3 · Cited by 471
Sharma, R., Khristov, V., Rising, A., Jha, B. S., Dejene, R., Hotaling, N., Li, Y., Stoddard, J., Stankewicz, C., Wan, Q., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aat5580 · Cited by 359
Poetsch, M. S., Strano, A., & Guan, K. (2022) · Stem Cells · doi:10.1093/stmcls/sxac020 · Cited by 144
The mutational impact of culturing human pluripotent and adult stem cells
Kuijk, E., Jager, M., van der Roest, B., Locati, M. D., Van Hoeck, A., Korzelius, J., Janssen, R., Besselink, N., Boymans, S., van Boxtel, R., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16323-4 · Cited by 124
Metadata
- Authors
- Kwon, E. M., Connelly, J. P., Hansen, N. F., Donovan, F. X., Winkler, T., Davis, B. W., Alkadi, H., Chandrasekharappa, S. C., Dunbar, C. E., Mullikin, J. C., & Liu, P.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2017-02-06
- Volume
- 114
- Issue
- 8
- Pages
- 1964-1969
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2586387028
- Cited by
- 76
- References
- 6
- FWCI
- 3.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: iPSCs and fibroblast subclones from the same fibroblast population contain comparable levels of sequence variations. https://app.cochat.ai/papers/10.1073/pnas.1616035114
- The paper
- Kwon, E. M., Connelly, J. P., Hansen, N. F., Donovan, F. X., Winkler, T., Davis, B. W., Alkadi, H., Chandrasekharappa, S. C., Dunbar, C. E., Mullikin, J. C., & Liu, P. (2017). iPSCs and fibroblast subclones from the same fibroblast population contain comparable levels of sequence variations. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1616035114
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.